Contact Us News & Media Font Size Home About Us Products Research Responsibility Investor Relations News & Media Careers HUGH O’NEILL Core Strengths Executive Team Executive Committee Mark Trudeau Mark Casey Meredith Fischer Matthew Harbaugh Ron Lloyd Hugh O'Neill Gary Phillips, M.D. Steven Romano, M.D. Dr. Frank Scholz Karen Sheehy Ian Watkins Select Senior Leaders Coleman Lannum Tunde Otulana, M.D. Dagmar Rosa-Björkeson Kathleen Schaefer Board of Directors 150th Anniversary Our Story Inclusion and Diversity Partnering News & Media Blog Patient Stories Careers at Mallinckrodt Community Outreach Investor Relations Hugh O’Neill Executive Vice President and President, Autoimmune and Rare Diseases Hugh O’Neill is executive vice president and president of autoimmune and rare diseases at Mallinckrodt Pharmaceuticals. He has executive responsibility and directly manages all commercialization efforts and broad market access activites for this portfolio within the company's Specialty Brands segment. Mr. O’Neill is a member of Mallinckrodt’s executive committee. Mr. O’Neill has more than 20 years of experience in new product planning and execution, business development, strategic planning, marketing, general management, finance and market access in the pharmaceutical industry. Before joining Mallinckrodt, Mr. O’Neill held various commercial leadership positions at Sanofi, including vice president of commercial excellence, general manager, president of Sanofi Canada, and vice president of market access and business development. He has also worked at Pharmacia, Novartis and Sandoz, crafting commercial strategies and operational plans across all facets of various organizations — including commercial coordination within research and development, new product launches, field force leadership, strategic marketing, business development, and market access. Mr. O’Neill holds a bachelor’s degree in finance from Montclair State University and an MBA in marketing from Seton Hall University. Back Building On Our Heritage Nearly 150 years of quality, integrity and service. Learn More Our Culture From philanthropic efforts to advocacy initiatives, we are living our hallmarks throughout our communities. Learn How Resources for: Career Seekers Investors Suppliers About Mallinckrodt: About Us Home Investor Relations News & Media Products Research Responsibility Other Links: Blog Calif. Supply Chain Disclosure Contact Us Patents Privacy Policy Safety Data Sheets Terms of Use UK Modern Slavery Act Disclosure Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Blog LinkedIn + Cookies Policy Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies setting, please read our Privacy Policy. By continuing to browse the site, you are agreeing to accept our use of cookies. I Agree ›